<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previously reported effects of lubeluzole, such as inhibition of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release, inhibition of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) synthesis and blockage of voltage-gated <z:chebi fb="1" ids="29101">Na+</z:chebi>- and <z:chebi fb="0" ids="29108">Ca2+</z:chebi>-ion channels, suggest a neuroprotective action of this drug </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report about the effects of lubeluzole and its R-isomer on <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> in mixed hippocampal cultures </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, we studied the effect of lubeluzole in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> models in mice and rats </plain></SENT>
<SENT sid="3" pm="."><plain>In hippocampal cultures exposed to 500 nM <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> for 1 h, lubeluzole (0.1-100 nM), but not the R-isomer (1-100 nM), reduced the percentage of damaged neurons from 42 +/- 8% to 18 +/- 7% (P &lt; 0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>In mice and rats, lubeluzole reduced ischemic brain damage, when administered immediately after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, the protective effect (reduction of the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in rats to 77% of control; P &lt; 0.01) was also found when the lubeluzole treatment (2.5 mg/kg) was started 3 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Especially this latter effect suggests that lubeluzole will be a useful drug for <z:hpo ids='HP_0001297'>stroke</z:hpo> therapy </plain></SENT>
</text></document>